Clinical Trial

The Multicentre Prospective Observational Study on the Management of Septic Shock

Study acronym: OSS
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Although there are published guidelines for the management of shock in general and septic shock in particular, the extent to which these guidelines are adhered to or achievable is unknown. Our study aims to describe, in a large population of critical care patients, the management procedures for septic shock, the applicability of existing guidelines, and the characteristics of the centres. The primary objective is to assess current clinical practices for the treatment and monitoring of patients with septic shock. The secondary objectives are to investigate the association of current clinical practices for the treatment and monitoring with 28-day all-cause mortality, to assess the association of current clinical practices for the treatment and monitoring with other outcomes, including 90-day all-cause mortality, ICU length of stay, days without renal replacement therapy, days without vasopressors support and days without invasive mechanical ventilation, to assess the factors that influence the disparity of practices, among the severity of the patients, the country, the availability of drugs and devices and to measure the relative frequency of balanced fluid and isotonic saline administration.
Trial Details
NCT Number NCT07453901
Lead Sponsor Bicetre Hospital
Conditions Septic Shock
Enrollment 5,000 participants
Start Date 2026-10-01
Primary Completion 2028-09-30 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-06